Biotech Stocks in News - NASDAQ:MNKD, NASDAQ:GNOM, NASDAQ:ARIA, NASDAQ:GALE

Pompano Beach, FL -- (SBWIRE) -- 01/09/2013 -- MannKind Corporation (NASDAQ:MNKD) reported that it will join The 31st Annual J.P. Morgan Healthcare Conference, which is going to be held at St. Francis Hotel in San Francisco, California on January 10,Thursday, at 8:00 AM (PST).

MannKind Corporation (NASDAQ:MNKD) remained among the day gainers and traded with volume of 4.11 million shares in the last session as compared to average volume of 2.49million shares.

Where MNKD is Headed Exactly? Find out in This Trend Analysis Reports

The stock on Tuesday increased 2.36% and finished the day at $2.60. MNKD was a gainer in the 5 days activity and jumped about 12.55%. The one month performance of stock was positive and it scored more than 22%.The 52 week range of the stock remained $1.57 - $3.48.

Complete Genomics, Inc. (NASDAQ:GNOM) started its trading session with the price $3.20, and closed at price of $3.15 by scoring -1.55%. The 52 week range of GNOM was $1.57-$5.42.

GNOM’s stocks traded with total volume of 3.93 million shares while the average trading capacity remained 469,890.00 shares.

Can GNOM Show a Strong Recovery? Find out in This Research Report

Previous 5 days graph demonstrated a positive move of 0.64%.GNOM’s quarterly performance remained green with the percentage of +2.27, while its six month performance showed that the stock advanced overall52.91%.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock’s trade opened at $18.75 and as day trade closed its price was $19.65after scoring 4.08% .The market capitalization of ARIA was 3.27 billion. Total traded volume of the stock was 3.04 million shares while company’s average volume remained 3.01 million shares.

ARIA’s day range remained $18.32 - $19.82 while its 52 week range was $13.42 - $25.40. The 5 days performance graph showed it as a percentage gainer with 2.45%.

Should ARIA a Buy or Sell Now?Find out in This Research Report

Galena Biopharma Inc (NASDAQ:GALE) traded with a plunge of -1.58% and closed at $1.87 after gaining total volume of 2.80 million shares its opening price remained $1.93.

Galena Biopharma Company’s earning per share is $-0.54 while its beta value stands at 0.67times.

If we look at previous 5 day’s performance of the stock, it remained jumping with the gain of 24.67%, in its last one month’s trade it dropped -9.22%.

What GALE’s Charts Are Signaling for Traders? Find Out Here

GALE has total market capitalization of $126.46 million while total of 67.63million outstanding shares.

About TopStockPlays
The TopStockPlays.com expert team is highly experienced in picking the low-priced shares with the biggest profit potential. We uncover the hidden gems in the stock market-shares that can break out for gains of 300%, 400%, even 500% within a few weeks.

Disclaimer
PLEASE NOTE WELL: The TopStockPlays.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. Please do your research or consults your financial adviser before making any Investment decision. TopStockPlays.com or its employees will not be responsible for any loss or losses.